Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 14, 2020

SELL
$29.93 - $50.1 $2,244 - $3,757
-75 Closed
0 $0
Q1 2020

Apr 17, 2020

SELL
$30.35 - $67.14 $303 - $671
-10 Reduced 11.76%
75 $3,000
Q4 2019

Jan 21, 2020

SELL
$55.65 - $79.83 $667 - $957
-12 Reduced 12.37%
85 $5,000
Q3 2019

Oct 28, 2019

SELL
$64.7 - $85.39 $1,229 - $1,622
-19 Reduced 16.38%
97 $7,000
Q2 2019

Jul 12, 2019

SELL
$67.77 - $82.2 $1,355 - $1,644
-20 Reduced 14.71%
116 $0
Q1 2019

Apr 26, 2019

SELL
$45.83 - $70.54 $1,374 - $2,116
-30 Reduced 18.07%
136 $0
Q4 2018

Jan 08, 2019

SELL
$41.17 - $56.44 $823 - $1,128
-20 Reduced 10.75%
166 $7,000
Q3 2018

Oct 04, 2018

BUY
$52.95 - $71.34 $1,588 - $2,140
30 Added 19.23%
186 $0
Q1 2018

Apr 04, 2018

BUY
$56.98 - $72.41 $8,888 - $11,295
156 New
156 $0

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.03B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.